Orbis Biosciences, Inc.
Orbis Biosciences specializes in oral and injectable controlled release technologies. The company was acquired by CDMO Adare Pharmaceuticals in May 2020, expanding its capabilities in developing innovative drug delivery solutions. Orbis Biosciences focuses on providing advanced controlled release technologies for oral and injectable medications, enhancing drug efficacy and patient adherence. With a strong emphasis on precision and customization, Orbis Biosciences plays a key role in the pharmaceutical industry by offering specialized solutions for complex dosing challenges.
Orbis Biosciences, Inc.
Orbis Biosciences specializes in oral and injectable controlled release technologies. The company was acquired by CDMO Adare Pharmaceuticals in May 2020, expanding its capabilities in developing innovative drug delivery solutions. Orbis Biosciences focuses on providing advanced controlled release technologies for oral and injectable medications, enhancing drug efficacy and patient adherence. With a strong emphasis on precision and customization, Orbis Biosciences plays a key role in the pharmaceutical industry by offering specialized solutions for complex dosing challenges.
adarepharmasolutions.com
8006 Reeder St Lenexa, Kansas 66214, US
Details
Year founded
2008
Revenue
1M-5M
Employees
1-10
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Abuse-Deterrent Testing
- Adaptdose™
- AdvaTab®
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Fluid bed processing technology for controlled-release beads/granules
- Particle sizing and coating equipment for controlled-release beads/granules
- Equipment for creating controlled release beadlets/granules
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that orbis biosciences is ramping up production.
Target industries
News
Controlled Release Drug Delivery Market to See Booming Growth
Controlled Release Drug Delivery Market to See Booming Growth
Press release - Coherent Market Insights - Controlled Release Drug Delivery Market to See Booming Growth 2024-2031 | Orbis Biosciences, Inc., Merck and Co.,...
Locations (1)
Orbis Biosciences, Inc.
8006 Reeder St Lenexa, Kansas 66214, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Orbis Biosciences, Inc. offer?
Orbis Biosciences, Inc. offers a range of services and capabilities, including Abuse-Deterrent Testing.
What kind of equipment does Orbis Biosciences, Inc. use?
Orbis Biosciences, Inc. uses a variety of equipment, including Fluid bed processing technology for controlled-release beads/granules.
What are the target industries of Orbis Biosciences, Inc.?
Orbis Biosciences, Inc. serves several industries, including the medical industry.
How many locations does Orbis Biosciences, Inc. operate?
Orbis Biosciences, Inc. operates from a single location at 8006 reeder street, lenexa, kansas 66214, united states.
Where are the headquarters of Orbis Biosciences, Inc.?
The headquarters of Orbis Biosciences, Inc. are located in 8006 reeder street, lenexa, kansas 66214, united states.
What is the NAICS code for Orbis Biosciences, Inc.?
The NAICS code for Orbis Biosciences, Inc. is 3254.
How many employees does Orbis Biosciences, Inc. have?
Orbis Biosciences, Inc. has an employee count in the range of 1-10 employees.
What is the official website of Orbis Biosciences, Inc.?
The official website of Orbis Biosciences, Inc. is https://adarepharmasolutions.com/.
When was Orbis Biosciences, Inc. founded?
Orbis Biosciences, Inc. was founded in 2008.